Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Official title:
Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation: a Randomised Feasibility Study
The investigators are carrying out a feasibility study to explore whether an app for physical activity in Chronic Obstructive Pulmonary Disease (COPD) is acceptable to people with the condition and to healthcare professionals who help patients manage the condition.
Chronic Obstructive Pulmonary Disease (COPD) is a long term lung condition which causes
breathlessness, tiredness, coughing and chest infections. People with the condition often
find it difficult to carry out day to day activities and to live a normal life. In recent
years people with COPD have been encouraged to self-manage their condition, for example by
increasing their physical activity, which could help them to live their life to the full.
Recent advances in technology have the potential to help people do this. The SMART COPD 'app'
which is being used in this study has been developed, based on previous research and the
views of people living with the condition, to help people with COPD increase their physical
activity. Physical activity is known to be important in helping people with COPD to enjoy
better health and to carry out activities. The current study will investigate whether or not
the app could be used alongside existing health services, and whether or not people with
COPD, as well as healthcare professionals, find the 'app' acceptable and easy to use.
The investigators are working with three Pulmonary Rehabilitation (PR) teams in South
Yorkshire (from Sheffield, Rotherham and Doncaster). PR is an education and exercise
programme for people with lung conditions, which aims to teach people the skills to help them
self-manage their condition. The first part of this feasibility study will investigate how PR
is currently being delivered, and whether there would be any scope to include the app during
and after PR to help people increase (or at least maintain) their physical activity levels
longer term. This will be done by observing PR sessions, looking at how PR is delivered and
referrals to the service, and through interactive workshops with healthcare professionals who
deliver PR. The second part of the project will involve 'trying out' the app with a small
group of people with COPD who are attending PR, to investigate whether the app is easy to
use, whether any changes are needed, and the best way to use the app in the future. In order
to determine whether the app successfully helps people with COPD to increase their physical
activity levels, the investigators will need to carry out a much larger study in the future
which compares use of the app with not having the app. The current feasibility project will
help with planning this much larger study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
Terminated |
NCT01388920 -
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
|
Phase 2 |